|
|
Clinical Efficacy, Safety and Quality of Life of Aripiprazole Combined with Fluvoxamine in the treatment of Obsessive-compulsive Disorder |
HUANG Yue |
Jinzhou Kangning Hospital, Liaoning Jinzhou 121013, China |
|
|
Abstract Objective: To study the effect of aripiprazole combined with fluvoxamine on clinical efficacy, survival therapy and safety in patients with obsessive-compulsive disorder. Methods: From April 2012 to March 2016, 216 patients with obsessive-compulsive disorder admitted to our hospital were divided into control group (n=103 cases) and study group (n=113 cases) according to different drug regimens. Patients in the control group were given non-convulsive electroconvulsive therapy combined with fluvoxamine. Patients in the study group were given aripiprazole on the basis of the control group. The scores of GQOLI-74, HAMA and Y-BCOS before and after treatment in two groups were compared, the clinical efficacy and safety of medication were compared. Results: There was no significant difference in the GQOLI-74 score between the two groups before treatment (P>0.05). The GQOLI-74 score of the study group after treatment was significantly higher than that of the control group, and there was a significant difference (P<0.05). The GQOLI-74 score of the two groups after treatment was significantly higher than that before treatment, and there were significant differences (P<0.05). There was no significant difference in the HAMA score between the two groups before treatment (P>0.05). The HAMA score of the study group after treatment was significantly lower than that of the control group, and there was a statistically significant difference (P<0.05). There was no significant difference in Y-BCOS score between the two groups before treatment (P>0.05). The Y-BCOS score of the study group was significantly lower than that of the control group (P<0.05). The Y-BCOS score of the two groups after treatment was significantly lower than that before treatment (P<0.05). The total effective rate was 77.67% in the control group, which was significantly lower than 92.92% in the study group (χ2= 4.509, P<0.05). Conclusion: Aripiprazole combined with fluvoxamine in the treatment of obsessive-compulsive disorder can improve the quality of life and effectively improve the psychiatric symptoms. The curative effect is better than that of fluvoxamine, and it is safer and worthy of clinical promotion.
|
|
|
|
|
[1] 白凤凤,李涛.阿立哌唑联合氟伏沙明治疗难治性强迫症的临床对照研究[J].天津药学,2014,26(3):22~25. [2] 邓怀丽,王斌红,张俊鸿.氟伏沙明联合阿立哌唑治疗强迫症的疗效观察[J].中国药物与临床,2015,15(5):719~721. [3] 周海平,钟远惠,何晓华.氟伏沙明联合思维阻断疗法治疗强迫症的效果观察[J].四川精神卫生,2015,28(5):407~410. [4] 张丽霞,冀成君,范宏振,等.图式治疗合用氟伏沙明治疗强迫症的随机对照研究[J].中国心理卫生杂志,2015,29(10):726~728. [5] 康瑞,康永兵.无抽搐电休克与喹硫平联合氟伏沙明治疗难治性强迫症的疗效比较[J].中国实用神经疾病杂志,2016,19(11):65~66. [6] 黄继伟,周刚柱.氟伏沙明合并喹硫平治疗难治性强迫症对照研究[J].中国健康心理学杂志,2013,21(5):666~667. [7] 程波.丁螺环酮联合帕罗西汀治疗焦虑症40例疗效分析[J].中国民康医学,2013,24(6):54~55. [8] 江小英,王艳涛,杨荣梅.氟伏沙明治疗强迫症对照研究疗效与安全性的Meta分析[J].海峡药学,2012,24(12):160~162. [9] 王雪梅,陈文,王振,等.早年创伤与强迫症发病的关联研究[J].中华行为医学与脑科学杂志,2016,25(12):1087~1090. |
|
|
|